Anavex Life Sciences Statistics
Total Valuation
AVXL has a market cap or net worth of $343.64 million. The enterprise value is $204.26 million.
| Market Cap | 343.64M |
| Enterprise Value | 204.26M |
Important Dates
The last earnings date was Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVXL has 84.64 million shares outstanding. The number of shares has increased by 5.31% in one year.
| Shares Outstanding | 84.64M |
| Shares Change (YoY) | +5.31% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 3.05% |
| Owned by Institutions (%) | 38.15% |
| Float | 82.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.55 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.12, with zero debt.
| Current Ratio | 15.12 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.00% and return on invested capital (ROIC) is -37.04%.
| Return on Equity (ROE) | -29.00% |
| Return on Assets (ROA) | -26.80% |
| Return on Capital (ROIC) | -37.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.01M |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVXL has paid $167,046 in taxes.
| Income Tax | 167,046 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.06% in the last 52 weeks. The beta is 0.66, so AVXL's price volatility has been lower than the market average.
| Beta (1Y) | 0.66 |
| 52-Week Price Change | -56.06% |
| 50-Day Moving Average | 4.18 |
| 200-Day Moving Average | 6.00 |
| Relative Strength Index (RSI) | 47.94 |
| Average Volume (30 Days) | 1,219,590 |
Short Selling Information
The latest short interest is 21.86 million, so 25.83% of the outstanding shares have been sold short.
| Short Interest | 21.86M |
| Short Previous Month | 21.29M |
| Short % of Shares Out | 25.83% |
| Short % of Float | 26.64% |
| Short Ratio (days to cover) | 18.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -49.99M |
| Pretax Income | -40.43M |
| Net Income | -40.59M |
| EBITDA | -40.43M |
| EBIT | -40.43M |
| Earnings Per Share (EPS) | -$0.51 |
Balance Sheet
The company has $139.39 million in cash and no debt, giving a net cash position of $139.39 million or $1.65 per share.
| Cash & Cash Equivalents | 139.39M |
| Total Debt | n/a |
| Net Cash | 139.39M |
| Net Cash Per Share | $1.65 |
| Equity / Book Value | 134.96M |
| Book Value Per Share | 1.59 |
| Working Capital | 134.96M |
Cash Flow
| Operating Cash Flow | -32.48M |
| Capital Expenditures | n/a |
| Free Cash Flow | -32.48M |
| FCF Per Share | -$0.39 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVXL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.31% |
| Shareholder Yield | -5.31% |
| Earnings Yield | -11.81% |
| FCF Yield | -9.45% |
Analyst Forecast
The average price target for AVXL is $40.00, which is 885.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.00 |
| Price Target Difference | 885.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 7, 2015. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 7, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |